Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing<i>Klebsiella pneumoniae</i>and<i>K. quasipneumoniae</i>highlights different evolutionary mechanisms
bioRxiv (Cold Spring Harbor Laboratory)